ch.oddb.org
 
Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
Vifor (International) Inc. - Flucelvax Tetra, Injektionssuspension
6748201
Flucelvax TetraInjektionssuspension
J07BB02Influenza, gereinigtes Antigen
04.05.2021  
Composition
haemagglutininum influenzae A (H3N2) (Virus Stamm A/Kansas/14/2017 (H3N2)-like: derived from A/Indiana/08/2018) 15 µg, haemagglutininum influenzae A (H1N1) (Virus Stamm A/Brisbane/02/2018 (H1N1)-like: derived from A/Idaho/07/2018) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Colorado/06/2017-like: reassortant from B/Iowa/06/2017 (Victoria lineage)) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Phuket/3073/2013-like: reassortant from B/Singapore/INFTT-16-0610/2016 (Yamagata lineage)) 15 µg, natrii chloridum, kalii chloridum, magnesii chloridum hexahydricum, natrii dihydrogenophosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.7 mg, kalium 0.1 mg, residui: polysorbatum 80, cetrimidum, propiolactonum.
Packungsbestandteile
Suspension injectable 
  
 
Principe actifConcentr.
Haemagglutininum Influenzae a (H1N1) (Virus Stamm A/brisbane/02/2018 (H1N1)-Like: Derived from A/idaho/07/2018)15µg / 0.5ml
Haemagglutininum Influenzae a (H3N2) (Virus Stamm A/kansas/14/2017 (H3N2)-Like: Derived from A/indiana/08/2018)15µg / 0.5ml
Haemagglutininum Influenzae b (Virus Stamm B/colorado/06/2017-Like: Reassortant from B/iowa/06/2017 (Victoria Lineage))15µg / 0.5ml
BAG: Principe actifConcentr.
Influenza-haemagglutinine60 mcg
 
Agents auxilliairesConcentr.
Haemagglutininum Influenzae b (Virus Stamm B/phuket/3073/2013-Like: Reassortant from B/singapore/inftt-16-0610/2016 (Yamagata Lineage))15µg / 0.5ml
Potassium Chlorure 
Potassium Dihydrogenophosphate 
Magnesium Chloride Hexahydrate 
Sodium Chlorure 
Sodium Dihydrogenophosphate Dihydrate 
 
numéro d'emballage Taille des présentationsPEFPPCat.LSHors commerce (MedRef)
00610DDPDDPB Non
00710DDPDDPB Non
2025 ©ywesee GmbH
Einstellungen | Aide | FAQ | Identification | Contact | Home